Topical Roflumilast in Adults With Atopic Dermatitis
NCT01856764
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
0.5% Roflumilast Cream
DRUG:
Vehicle Cream
Sponsor
AstraZeneca